Physician profile
Dara Lianna Aisner
NPI 1538321831
$23,227.54
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,919 · 2021: $5,218 · 2022: $8,936 · 2023: $6,047 · 2024: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,125 · Travel and Lodging: $735 · Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,125.00 |
| Travel and Lodging | $735.00 |
| Food and Beverage | $294.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $4,232.15 | 2020-2024 | Tagrisso |
| Takeda Pharmaceuticals U.S.A., INC. | $3,025.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,992.68 | 2022 | |
| Blueprint Medicines Corporation | $2,880.00 | 2020 | |
| Genzyme Corporation | $2,248.00 | 2022 | |
| Abbvie INC. | $2,100.00 | 2023 | |
| Genentech USA, INC. | $2,054.71 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $2,000.00 | 2021 | |
| Genentech, INC. | $1,695.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Aisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.